ID   DDCS2
AC   CVCL_B6GT
DR   Wikidata; Q111733154
RX   PubMed=34767468;
CC   Doubling time: 60-72 hours (PubMed=34767468).
CC   Derived from site: In situ; Right distal femur, cartilage; UBERON=UBERON_0010129.
ST   Source(s): PubMed=34767468
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 14
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 12,15
ST   D21S11: 30,32.2
ST   D2S1338: 22,25
ST   D3S1358: 14,17
ST   D5S818: 8
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 23
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C6476; Dedifferentiated chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 5
//
RX   PubMed=34767468; DOI=10.1177/10732748211045274; PMCID=PMC8645311;
RA   Li, Xiao-Yang
RA   Dean, Dylan C.
RA   Ferreira, Al
RA   Nelson, Scott D.
RA   Hornicek, Francis John
RA   Yu, Sheng-Ji
RA   Duan, Zhen-Feng
RT   "Establishment and characterization of a novel dedifferentiated
RT   chondrosarcoma cell line DDCS2.";
RL   Cancer Control 28:10732748211045274.1-10732748211045274.11(2021).
//